Currently, Mikhail Blagosklonny is serving as the Professor of Oncology. This is at the highly prestigious Roswell Park Cancer Institute. Mikhail Blagosklonny has been working on this position since 15th April 2009. Before this, he was working as a Senior Scientist. This was at the Ordway Research Institute which is located in Albany, New York. He had been appointed as the Associate Professor of Medicine. This was at the New York Medical College which is located at Valhalla in New York City.In addition, Mikhail Blagosklonny is the Editor-in Chief of Oncotarget. Also, he is on the Editorial Board of the journal, Cell Death, and Differentiation.In the same journal, he is the Associate Editor of Cancer Biology and Therapy. He is also the Founder Editor as well as Editor-in-Chief of the journal, Cell Cycle.He received his degree from the First Pavlov State Medical University of St Petersburg. He did his M.D. in Internal Medicine. He holds a Ph.D. degree in Experimental Medicine as well as Cardiology.
His educational qualifications make him perfect for the role he played in TOR signaling for aging along with cancer.Mikhail Blagosklonny advocates using Rapamycin for the longevity of life. This drug is mainly used for cancer till now. Mikhail Blagosklonny has done research on cancer along with the target cancer therapies. His research on Mechanisms of Aging has proposed using of Rapamycin as a drug for anti-aging.There are many publications under the name of Mikhail Blagosklonny. He is the publisher of over 270 papers. He has also used over 25,000 citations. This is why his h-index is 83.Mikhail Blagosklonny is a highly accomplished Physician, as well as Scientist besides being a Professor of Medicine along with Oncology.He is very passionate about Bio gerontology and has proposed using Rapamycin in order to enhance life.Mikhail Blagosklonny has worked in Ordway Research Institute as a senior scientist. In 2009 he moved from here to join Roswell Park Cancer Institute as their professor of oncology.
He is interested in doing research on targeted cancer therapies. These keep normal cells away from damage by using chemotherapy as well as radioactive rays. Besides, his interests include the mechanism of aging (biogerontology) and other anti-aging treatments. Others include cellular as well as molecular biology along with clinical investigations. The research of Mikhail Blagosklonny includes cell cycle, and anti-cancer therapeutics, along with cellular senescence, as well as signal transduction.He has a passion for studying signal transduction pathways. These lead from cancer to aging. This was where he was able to reveal potential targets which help to slow down the aging process and other illnesses that are age-related.His interest in cancer, as well as aging, has led Mikhail Blagosklonny to postulate a theory on the probable role played by TOR in cancer and in aging too. This is why he proposes using rapamycin for extending the life of a person.The staff at Roswell Park Cancer Institute was excited at his appointment to this institution.